OPK Stock Analysis: Buy, Sell, or Hold?
OPK - Opko Health Inc.
$1.28
0.01 (1.19%)
▲
5d:
-1.92%
30d:
+1.19%
90d:
-12.67%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 26, 2026
23d
Get Alerted When OPK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OPK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OPK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OPK is currently trading at $1.27, which is considered oversold relative to its 30-day fair value range of $1.27 to $1.34.
Technical Outlook: Technically, OPK is in a strong downtrend. The price is currently testing key support at $1.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OPK has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.56 (+182.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OPK is in a strong downtrend. The price is currently testing key support at $1.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OPK has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.56 (+182.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.27 -
$1.34
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 182.4% below Wall St target ($3.56)
Fair Price Analysis
30-Day Fair Range
$1.27 -
$1.34
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.24
Resistance Level
$1.43
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.06
Wall Street Target
$3.56
(+182.4%)
Revenue Growth (YoY)
-12.6%
Earnings Growth (YoY)
-12.6%
Profit Margin
-28.1%
Last updated: February 02, 2026 2:41 PM ET
Data refreshes hourly during market hours. Next update: 3:41 PM
Data refreshes hourly during market hours. Next update: 3:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPK showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Phillip Md Et Al Frost
BUY
675000 shares
2025-08-08
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$666 | 49 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 51 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$125 | 60 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 55 HOLD |
